Rights and permissions
About this article
Cite this article
PEP should be better targeted in France to enhance cost effectiveness. Inpharma Wkly. 1482, 4 (2005). https://doi.org/10.2165/00128413-200514820-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514820-00011